HeXun Biosciences Co., Ltd. (TPEX:6986)

Taiwan · Delayed Price · Currency is TWD

40.00

+2.50 (6.67%)

Nov 13, 2026, 1:30 PM CST

HeXun Biosciences Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	305.13	293.23	286.42	130.57	49.47	-
Revenue Growth	4.92%	2.38%	119.36%	163.94%	-	-
Gross Profit	282.31	266.28	260.67	113.73	44.61	-
Operating Income	136.61	118.01	155.73	27.37	-8.98	-50.66
Net Income	142.73	111.91	147.22	33.49	-5.19	-42.99
Earnings Per Share	3.00	2.43	3.20	0.74	-0.14	-1.41
EPS Growth	22.81%	-24.06%	332.90%	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Taiwan	289.14	282.49	286.42	130.57	49.47
Other	-	10.74	-	-	-
Total	308.21	293.23	286.42	130.57	49.47

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	845.69	509.63	372.99	329.67	191.74	85.03
Total Debt	33.62	36.58	35.02	72.61	71.64	74.1
Net Cash (Debt)	812.07	473.05	337.97	257.06	120.11	10.93
Net Cash Growth	77.12%	39.97%	31.47%	114.03%	999.17%	-
Net Cash Per Share	17.06	10.28	7.34	5.67	3.20	0.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	105.42	163.89	120.92	43.09	11.23	-35.5
Capital Expenditures	-34.08	-27.29	-37.29	-20.67	-1.23	-
Free Cash Flow	71.34	136.61	83.63	22.42	10	-35.5
Free Cash Flow Growth	-54.34%	63.36%	272.98%	124.19%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	92.52%	90.81%	91.01%	87.10%	90.18%	-
Operating Margin	44.77%	40.24%	54.37%	20.96%	-18.15%	-
Pretax Margin	57.56%	42.95%	56.38%	25.65%	-10.49%	-
Profit Margin	46.78%	38.16%	51.40%	25.65%	-10.49%	-
FCF Margin	23.38%	46.59%	29.20%	17.17%	20.22%	-

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Nov '26 Nov 15, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	0.220	0.220
Dividend Per Share Growth	0%	-
Dividend Yield	0.55%	0.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.35	25.90	21.09	89.01	-	-
P/FCF Ratio	29.23	21.21	37.13	132.95	-	-
PS Ratio	6.83	9.88	10.84	22.83	-	-